JP2022523766A5 - - Google Patents

Info

Publication number
JP2022523766A5
JP2022523766A5 JP2021549291A JP2021549291A JP2022523766A5 JP 2022523766 A5 JP2022523766 A5 JP 2022523766A5 JP 2021549291 A JP2021549291 A JP 2021549291A JP 2021549291 A JP2021549291 A JP 2021549291A JP 2022523766 A5 JP2022523766 A5 JP 2022523766A5
Authority
JP
Japan
Prior art keywords
raav
pharmaceutical composition
composition according
coding sequence
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021549291A
Other languages
English (en)
Japanese (ja)
Other versions
JP7637058B2 (ja
JP2022523766A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/019149 external-priority patent/WO2020172490A1/en
Publication of JP2022523766A publication Critical patent/JP2022523766A/ja
Publication of JP2022523766A5 publication Critical patent/JP2022523766A5/ja
Priority to JP2025022078A priority Critical patent/JP2025081439A/ja
Application granted granted Critical
Publication of JP7637058B2 publication Critical patent/JP7637058B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021549291A 2019-02-22 2020-02-21 Grn関連成人発症性神経変性の治療のための組換えアデノ随伴ウイルス Active JP7637058B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025022078A JP2025081439A (ja) 2019-02-22 2025-02-14 Grn関連成人発症性神経変性の治療のための組換えアデノ随伴ウイルス

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962809329P 2019-02-22 2019-02-22
US62/809,329 2019-02-22
US201962923812P 2019-10-21 2019-10-21
US62/923,812 2019-10-21
US202062969108P 2020-02-02 2020-02-02
US62/969,108 2020-02-02
PCT/US2020/019149 WO2020172490A1 (en) 2019-02-22 2020-02-21 Recombinant adeno-associated virus for treatment of grn-associated adult-onset neurodegeneration

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025022078A Division JP2025081439A (ja) 2019-02-22 2025-02-14 Grn関連成人発症性神経変性の治療のための組換えアデノ随伴ウイルス

Publications (3)

Publication Number Publication Date
JP2022523766A JP2022523766A (ja) 2022-04-26
JP2022523766A5 true JP2022523766A5 (cg-RX-API-DMAC7.html) 2023-02-17
JP7637058B2 JP7637058B2 (ja) 2025-02-27

Family

ID=70058449

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021549291A Active JP7637058B2 (ja) 2019-02-22 2020-02-21 Grn関連成人発症性神経変性の治療のための組換えアデノ随伴ウイルス
JP2025022078A Pending JP2025081439A (ja) 2019-02-22 2025-02-14 Grn関連成人発症性神経変性の治療のための組換えアデノ随伴ウイルス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025022078A Pending JP2025081439A (ja) 2019-02-22 2025-02-14 Grn関連成人発症性神経変性の治療のための組換えアデノ随伴ウイルス

Country Status (16)

Country Link
US (2) US12416017B2 (cg-RX-API-DMAC7.html)
EP (1) EP3927381A1 (cg-RX-API-DMAC7.html)
JP (2) JP7637058B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210131370A (cg-RX-API-DMAC7.html)
CN (1) CN113710281A (cg-RX-API-DMAC7.html)
AU (1) AU2020225472A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021015817A2 (cg-RX-API-DMAC7.html)
CA (1) CA3129672A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021002172A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021011040A2 (cg-RX-API-DMAC7.html)
IL (1) IL285654A (cg-RX-API-DMAC7.html)
MX (1) MX2021010134A (cg-RX-API-DMAC7.html)
PE (1) PE20211819A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202108504YA (cg-RX-API-DMAC7.html)
TW (1) TW202045730A (cg-RX-API-DMAC7.html)
WO (1) WO2020172490A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3917539A4 (en) * 2019-02-01 2022-11-23 Avrobio, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROCOGNITIVE DISORDERS
MX2021010134A (es) 2019-02-22 2021-09-23 Univ Pennsylvania Virus adenoasociado recombinante para el tratamiento de la neurodegeneracion de inicio en adultos asociada a grn.
GB201913974D0 (en) 2019-09-27 2019-11-13 King S College London Vector
IL292382A (en) * 2019-10-22 2022-06-01 Applied Genetic Tech Corporation Adeno-associated virus (aav) systems for treatment of progranulin associated neurodegenerative diseases or disorders
AU2021332331A1 (en) * 2020-08-26 2023-03-09 The Trustees Of The University Of Pennsylvania Recombinant adeno-associated virus for treatment of GRN-associated adult-onset neurodegeneration
JPWO2022131322A1 (cg-RX-API-DMAC7.html) * 2020-12-17 2022-06-23
WO2023150506A2 (en) * 2022-02-01 2023-08-10 Shape Therapeutics Inc. STABLE CELL LINES FOR INDUCIBLE PRODUCTION OF rAAV VIRIONS
WO2024245120A1 (en) * 2023-05-26 2024-12-05 Shanghai Vitalgen Biopharma Co., Ltd. Recombinant aav vectors for treating proteinopathies in central nervous system
EP4731669A2 (en) * 2023-06-21 2026-04-29 Eli Lilly and Company Compounds for the delivery of granulin across the blood brain barrier
TW202548022A (zh) * 2024-03-03 2025-12-16 美商帕西奇生物公司 用於治療神經退化性病症之重組腺相關病毒

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5436146A (en) 1989-09-07 1995-07-25 The Trustees Of Princeton University Helper-free stocks of recombinant adeno-associated virus vectors
US6268213B1 (en) 1992-06-03 2001-07-31 Richard Jude Samulski Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
US5869305A (en) 1992-12-04 1999-02-09 The University Of Pittsburgh Recombinant viral vector system
US6204059B1 (en) 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer
US6093570A (en) 1995-06-07 2000-07-25 The University Of North Carolina At Chapel Hill Helper virus-free AAV production
US5741683A (en) 1995-06-07 1998-04-21 The Research Foundation Of State University Of New York In vitro packaging of adeno-associated virus DNA
EP1007637B1 (en) 1997-04-14 2004-06-30 Cell Genesys, Inc. Methods for increasing the efficiency of recombinant aav product
US6146874A (en) 1998-05-27 2000-11-14 University Of Florida Method of preparing recombinant adeno-associated virus compositions
DE69936104T2 (de) 1998-11-05 2008-01-17 The Trustees Of The University Of Pennsylvania Nukleinsäuresequenzen des adeno-assoziierten virus des serotyps i, und vektoren und wirtszellen, die diese enthalten
US6759237B1 (en) 1998-11-05 2004-07-06 The Trustees Of The University Of Pennsylvania Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
EP1135468B1 (en) 1998-11-10 2010-01-06 University Of North Carolina At Chapel Hill Virus vectors and methods of making and administering the same
AU6814901A (en) 2000-06-01 2001-12-11 Univ North Carolina Methods and compounds for controlled release of recombinant parvovirus vectors
CN103589692B (zh) 2001-11-13 2018-07-24 宾夕法尼亚大学托管会 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法
AU2003274397A1 (en) 2002-06-05 2003-12-22 University Of Florida Production of pseudotyped recombinant aav virions
EP1668143B1 (en) 2003-09-30 2013-03-20 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
DE23193606T1 (de) 2005-04-07 2024-02-15 The Trustees Of The University Of Pennsylvania Verfahren zur erhöhung der funktion eines aav-vektors
US7588772B2 (en) 2006-03-30 2009-09-15 Board Of Trustees Of The Leland Stamford Junior University AAV capsid library and AAV capsid proteins
JP5123936B2 (ja) 2006-05-30 2013-01-23 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ 認知症の検出および治療
HUE044182T2 (hu) 2006-06-07 2019-10-28 Genzyme Corp Génterápia amiotrófiás laterális szklerózis és más gerincvelõ-rendellenességek kezelésére
WO2009089635A1 (en) 2008-01-16 2009-07-23 Neurodyn, Inc. Treating neurodegenerative diseases with progranulin (pgrn)
SI3988660T1 (sl) 2009-05-02 2025-09-30 Genzyme Corporation Genska terapija za nevrodegenerativne motnje
US20110203007A1 (en) 2010-02-16 2011-08-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Assays of neurodegenerative disorders, including frontotemporal dementia and amyotrophic lateral sclerosis
WO2011126808A2 (en) 2010-03-29 2011-10-13 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
US9315825B2 (en) 2010-03-29 2016-04-19 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
CA2818253A1 (en) 2010-11-16 2012-05-24 Denis G. Kay Method for increasing neprilysin expression and activity
FR2977562B1 (fr) 2011-07-06 2016-12-23 Gaztransport Et Technigaz Cuve etanche et thermiquement isolante integree dans une structure porteuse
WO2015164723A1 (en) * 2014-04-25 2015-10-29 The Trustees Of The University Of Pennsylvania Methods and compositions for treating metastatic breast cancer and other cancers in the brain
EA201791803A1 (ru) * 2015-02-10 2017-11-30 Джензим Корпорейшн Улучшенная доставка вирусных частиц в полосатое тело и кору больших полушарий
AU2016343979A1 (en) * 2015-10-29 2018-05-10 Voyager Therapeutics, Inc. Delivery of central nervous system targeting polynucleotides
US20190060359A1 (en) 2015-11-02 2019-02-28 Neuraltus Pharmaceuticals, Inc. Treatment of neurodegenerative disease with sodium chlorite
WO2017100674A1 (en) 2015-12-11 2017-06-15 The Trustees Of The University Of Pennsylvania Scalable purification method for aav1
US11015174B2 (en) 2015-12-11 2021-05-25 The Trustees Of The University Of Pennsylvania Scalable purification method for AAV8
EP3992283A1 (en) 2015-12-11 2022-05-04 The Trustees Of The University Of Pennsylvania Scalable purification method for aavrh10
EP3387138B2 (en) 2015-12-11 2026-05-27 The Trustees Of The University Of Pennsylvania Scalable purification method for aav9
MA43968A (fr) 2016-02-03 2018-12-12 Univ Pennsylvania Thérapie génique pour traiter la mucopolysaccharidose de type i
CA3016314A1 (en) 2016-03-02 2017-09-08 Julianne REIDERS Therapy for frontotemporal dementia
WO2018013775A2 (en) 2016-07-14 2018-01-18 Emory University Granulin compositions and uses related thereto
WO2018045347A1 (en) 2016-09-02 2018-03-08 Spark Therapeutics, Inc. Methods and vectors for treating cns disorders
RS65241B1 (sr) 2017-02-28 2024-03-29 Univ Pennsylvania Vektor adeno-asociranih virusa (aav) iz podgrupe f i njegove upotrebe
MX2020004005A (es) 2017-10-03 2020-10-05 Prevail Therapeutics Inc Terapias genicas para los trastornos lisosomales.
EP3692158A4 (en) 2017-10-03 2021-08-04 Prevail Therapeutics, Inc. GENE THERAPIES FOR LYSOSOMAL DISEASES
US20200283800A1 (en) 2017-10-23 2020-09-10 Prevail Therapeutics, Inc. Gene therapies for neurodegenerative diseases
EP3917539A4 (en) 2019-02-01 2022-11-23 Avrobio, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROCOGNITIVE DISORDERS
MX2021010134A (es) 2019-02-22 2021-09-23 Univ Pennsylvania Virus adenoasociado recombinante para el tratamiento de la neurodegeneracion de inicio en adultos asociada a grn.
AU2021332331A1 (en) 2020-08-26 2023-03-09 The Trustees Of The University Of Pennsylvania Recombinant adeno-associated virus for treatment of GRN-associated adult-onset neurodegeneration

Similar Documents

Publication Publication Date Title
JP2023144087A (ja) 組換えGlut1アデノ随伴ウイルスベクターコンストラクトおよびGlut1発現を回復させる方法
JP2023106497A (ja) 減少した免疫反応性を有するaavビリオン、およびその使用
AU2023202598B2 (en) Intrathecal delivery of recombinant Adeno-associated virus encoding Methyl-CpG binding protein 2
US20260049336A1 (en) Bicistronic aav vectors encoding hexosaminidase alpha and beta-subunits and uses thereof
US20250041453A1 (en) Methods and compositions for treating bag-3 related cardiomyopathy with a viral vector
EP2391388A1 (en) Methods for distributing high levels of therapeutic agent throughout the cortex to treat neurological disorders
JP2025138648A (ja) Cln3ポリヌクレオチドのアデノ随伴ウイルス送達
US20250041452A1 (en) Methods and compositions for treating mybpc3 related hypertrophic cardiomyopathy with a viral vector
US20250041450A1 (en) Adeno-associated virus particles and methods of use thereof
CN113574176A (zh) 腺相关病毒对cln6多核苷酸的递送
WO2023178338A2 (en) Methods and compositions for treating tmem43 related cardiomyopathy with a viral vector
JP2025509864A (ja) ウイルスベクターによりrbm20関連心筋症を処置するための方法および組成物
JP2024528997A (ja) 放射線誘発性唾液機能低下を予防するためのaqp1遺伝子療法
CA3240197A1 (en) Compositions comprising kozak sequences selected for enhanced expression
US20220136005A1 (en) One-step gene therapy for duchenne muscular dystrophy via gene replacement and anti-inflammation
CA2978917C (en) Recombinant glut1 adeno-associated viral vector constructs and related methods for restoring glut1 expression
HK40063258A (zh) 腺相关病毒对cln6多核苷酸的递送
WO2022170038A1 (en) Adeno-associated virus delivery of cln3 polynucleotide
Gregorevic et al. Functional enhancement of skeletal muscle by gene transfer
JP2021527418A (ja) ジストログリカノパチーおよびラミニン欠損筋ジストロフィーを治療するための組換えアデノ随伴ウイルス生成物および方法